2-(Arylmethyl)arylacetic acids as potential antiinflammatory agents.
D000818:Animals; D000893:Anti-Inflammatory Agents; D002351:Carrageenan / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D007192:Indenes; D008297:Male; D010648:Phenylacetates / Q000138:chemical synthesis* / Q000494:pharmacology; D051381:Rats
D000893:Anti-Inflammatory Agents; D007192:Indenes; D010648:Phenylacetates; D002351:Carrageenan